Pretreatment serum levels of myeloid-derived suppressor cells (MDSC) are effective as a prognostic indicator in patients with breast cancer.
Kenji Gonda
No relevant relationships to disclose
Masahiko Shibata
No relevant relationships to disclose
Takahiro Nakajima
No relevant relationships to disclose
Yoshiko Matsumoto
No relevant relationships to disclose
Noriko Abe
No relevant relationships to disclose
Tohru Ohtake
No relevant relationships to disclose
Tatsuo Shimura
No relevant relationships to disclose
Seiichi Takenoshita
No relevant relationships to disclose